Shares of Artiva Biotherapeutics Inc. (ARTV) have more than doubled year-to-date, driven by continued progress in its lead AlloNK program.
AlloNK is an off-the-shelf cell therapy made from donor immune cells (NK cells) that are frozen and stored until needed. It helps antibody drugs work better by boosting their ability to drive deep B-cell depletion.
Deep B-cell depletion mechanism of action represents potential to address limitations of existing therapies by providing durable clinical improvement.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.